Skip to main content
Premium Trial:

Request an Annual Quote

NorDiag and Genpoint Collaborate on DNA-Extraction Technology

NEW YORK (GenomeWeb News) – Genpoint will help NorDiag automate and improve its DNA-extraction technology, NorDiag said today.
The collaboration will focus on improving the Norwegian company’s method for isolating human DNA from stool in order for it to develop an product containing instruments, software, and reagents.
Earlier this year, Transgenomic licensed its WAVE system to NorDiag to detect mutations in its panel of proprietary and in-licensed markers for colorectal cancer.
Financial details were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.